To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04303858
Title A Study to Evaluate Safety and Anti-Tumor Activity of RO7284755 Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL | NLD | ESP | DNK | CAN | BEL

Facility Status City State Zip Country Details
Cliniques Universitaires St-Luc Bruxelles 1200 Belgium Details
UZ Leuven Gasthuisberg Leuven 3000 Belgium Details
Princess Margaret Cancer Center Toronto Ontario M5G 2M9 Canada Details
Herlev Hospital Herlev 2730 Denmark Details
Rigshospitalet København Ø 2100 Denmark Details
NKI/AvL Amsterdam 1066 CX Netherlands Details
Erasmus MC Rotterdam 3015 GD Netherlands Details
Uniwersyteckie Centrum Kliniczne Gda?sk 80-214 Poland Details
Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie Warszawa 02-781 Poland Details
Clinica Universitaria de Navarra Pamplona Navarra 31008 Spain Details
Hospital del Mar Barcelona 08003 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Hospital Clinic Barcelona Barcelona 08036 Spain Details
START Madrid-FJD, Hospital Fundacion Jimenez Diaz Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field